Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease

N Guzior, A Wieckowska, D Panek… - Current medicinal …, 2015 - ingentaconnect.com
Alzheimer's disease (AD) is a complex and progressive neurodegenerative disorder. The
available therapy is limited to the symptomatic treatment and its efficacy remains …

Recent advancements in the development of bioactive pyrazoline derivatives

B Nehra, S Rulhania, S Jaswal, B Kumar… - European journal of …, 2020 - Elsevier
Pyrazolines remain privileged heterocycles in drug discovery. 2-Pyrazoline scaffold has
been proven as a ubiquitous motif which is present in a number of pharmacologically …

Privileged scaffolds as MAO inhibitors: Retrospect and prospects

AC Tripathi, S Upadhyay, S Paliwal, SK Saraf - European Journal of …, 2018 - Elsevier
This review aims to be a comprehensive, authoritative, critical, and readable review of
general interest to the medicinal chemistry community because it focuses on the …

Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies

A Kumar, M Bhatia, A Kapoor, P Kumar… - European Journal of …, 2022 - Elsevier
Monoamine oxidase enzyme is necessary for the management of brain functions. It
oxidatively metabolizes monoamines and produces ammonia, aldehyde and hydrogen …

Pyrazoline containing compounds as therapeutic targets for neurodegenerative disorders

MJ Ahsan, A Ali, A Ali, A Thiriveedhi, MA Bakht… - ACS …, 2022 - ACS Publications
Pyrazolines are a significant class of heterocyclic compounds with essential biological
activities. They are quite stable, which has inspired medicinal chemists to experiment with …

Recent developments on the structure–activity relationship studies of MAO inhibitors and their role in different neurological disorders

B Kumar, AK Mantha, V Kumar - RSC advances, 2016 - pubs.rsc.org
Monoamine oxidase (MAO) enzyme catalyzes the oxidative deamination of xenobiotic and
endogenous amines including many neurotransmitters. The MAO enzyme exists in two …

Pyrazolines: a biological review

A Marella, R Ali, T Alam, R Saha… - Mini reviews in …, 2013 - ingentaconnect.com
Pyrazoline is an important five membered nitrogen heterocycle, which has been extensively
researched upon. The ring is quite stable and has inspired chemists to carry out various …

Synthesis and biological evaluation of new pyrazolone Schiff bases as monoamine oxidase and cholinesterase inhibitors

F Tok, B Koçyiğit-Kaymakçıoğlu, BN Sağlık, S Levent… - Bioorganic …, 2019 - Elsevier
In the current work, Schiff base derivatives of antipyrine were synthesized. The chemical
characterization of the compounds was confirmed using IR, 1 H NMR, 13 C NMR and mass …

[HTML][HTML] Synthetic and biological studies of pyrazolines and related heterocyclic compounds

M Yusuf, P Jain - Arabian Journal of Chemistry, 2014 - Elsevier
This review provides a comprehensive survey relating to the synthesis and biological
applications of pyrazolines and related heterocycles in the last five years (2007–2011) …

The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents

D Secci, A Bolasco, P Chimenti… - Current medicinal …, 2011 - ingentaconnect.com
Monoamine oxidase plays a significant role in the control of intracellular concentration of
monoaminergic neurotransmitters or neuromodulators and dietary amines. The rapid …